The American Journal of Medicine
Volume 80, Issue 2, Supplement 1 , Pages 1-2 , 14 February 1986

Introduction

  • Robert I. Levy, M.D.

      Affiliations

    • Corresponding Author InformationRequests for reprints should be addressed to Dr. Robert I. Levy, Columbia University College of Physicians and Surgeons, 630 West 168th Street, New York, New York 10032.
    • Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New YorkUSA
    • Department of Medicine, Oslo University Medical School, Medical Outpatient Clinic, Ullevaal Hospital, Oslo, Norway
    • ,
  • Paul Leren, M.D.

      Affiliations

    • Department of Medicine, Columbia University College of Physicians and Surgeons, New York, New YorkUSA
    • Department of Medicine, Oslo University Medical School, Medical Outpatient Clinic, Ullevaal Hospital, Oslo, Norway

References 

  1. Levy RI, Feinlieb M. Risk factors for coronary artery disease and their management. In:  Braunwald E editors. Heart disease. Philadelphia: W.B. Saunders; 1984;p. 1203
  2. Inter-Society Commission for Heart Disease Resources . Atherosclerosis Study Group (W.B. Kannel, chairman). In: Optimal resources for primary prevention of atherosclerotic diseases. Circulation. 70:1984;p. 157A–205A
  3. The National Institutes of Health Consensus Development Conference . Lowering blood cholesterol to prevent heart disease. JAMA. 1985;253:2080–2086
  4. Multiple Risk Factor Intervention Trial Research Group. Multiple Risk Factor Intervention Trial: risk factor changes and mortality results. JAMA. 1982;248:1465–1477
  5. Medical Research Council Working Party . MRC trial of treatment of mild hypertension: principal results. Br Med J. 1985;291:97–104
  6. Ames RP, Hill P. Increase in serum lipids during treatment of hypertension with chlorthalidone. Lancet. 1976;I:721–723
  7. Goldman AI, Steele BW, Schnaper HW, Fitz AE, Frohlich ED, Perry HM. Serum lipoprotein levels during chlorthalidone therapy. JAMA. 1980;244:1691–1695
  8. Lipid Research Clinics Program . The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease. JAMA. 1984;251:351–364
  9. Lipid Research Clinics Program . The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering. JAMA. 1984;251:365–374

PII: 0002-9343(86)90152-X

The American Journal of Medicine
Volume 80, Issue 2, Supplement 1 , Pages 1-2 , 14 February 1986

Article Tools